Notice2022-21263
National Institute of Mental Health; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 30, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 189 (Friday, September 30, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 189 (Friday, September 30, 2022)]
[Notices]
[Page 59446]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-21263]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Advanced Laboratories for Accelerating the Reach and
Impact of Treatments for Youth and Adults with Mental Illness (P50).
Date: October 25, 2022.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Serena Chu, Ph.D., Scientific Review Officer,
Division of Extramural Activities, National Institute of Mental
Health, National Institutes of Health Neuroscience Center, 6001
Executive Blvd., Room 6000, MSC 9606, Bethesda, MD 20852, 301-500-
5829, <a href="/cdn-cgi/l/email-protection#a9daccdbccc7c887cac1dce9c7c0c187cec6df"><span class="__cf_email__" data-cfemail="d5a6b0a7b0bbb4fbb6bda095bbbcbdfbb2baa3">[email protected]</span></a>.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Early-Stage Clinical Trials of Pharmacologic or
Device-Based Interventions.
Date: October 26, 2022.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606, Bethesda, MD 20892-9606
301-443-9699 <a href="/cdn-cgi/l/email-protection#8fedfafdfcfbeae6e1e2eacfe2eee6e3a1e1e6e7a1e8e0f9"><span class="__cf_email__" data-cfemail="c0a2b5b2b3b4a5a9aeada580ada1a9aceeaea9a8eea7afb6">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: September 26, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-21263 Filed 9-29-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 30, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.